Translational research: crossing the valley of death
Paper cited by one bottleneck page and twelve idea pages, indexed on Europe PMC as PubMed record 18548043 and published in Nature; the citing pages link this DOI, which is how the record was matched.
Overview
Europe PMC indexes no abstract for this record; the title is the only text available.
Indexed on Europe PMC as PubMed record 18548043 (DOI 10.1038/453840a). Matched by DOI alone: one bottleneck page and twelve idea pages cite this DOI among their external links (the pages are listed under Related), and this page was written so that the citation resolves inside OnCo. No figure has been checked by an editor.
One bottleneck page and twelve idea pages on OnCo cite this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing pages listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
- Matched to the citing OnCo records by DOI alone; the summary reproduces the Europe PMC abstract and no figure has been verified against the full paper.
Similar pages
not linked directly; found by shared links- IdeaRegional translational institutes with academic GMP suites and IND teams
Shares Two-year translational fellowships that pay scientists to develop their own discovery, A national non-profit contract research organisation for academic oncology trials, A global first-in-human network for academic cancer trials with single ethics review, Hospital-exemption cell therapies at scale, backed by a shared registry.
- IdeaA fast IND-enabling fund that pays for toxicology and manufacturing in eight weeks
Shares A diversified royalty pool that finances academic phase 1 trials across fifty assets, A phase 0 fund to test academic compounds in humans with microdoses and imaging, The valley of death between lab and product.
- IdeaFunded research pathways for surgeon-scientists and radiation oncologist-scientists
Shares Hospital-funded protected time for clinician-scientists, repaid by trial revenue, Two-year translational fellowships that pay scientists to develop their own discovery.
- IdeaForty-eight-hour small grants for bold experiments in neglected cancers
Shares A phase 0 fund to test academic compounds in humans with microdoses and imaging, The valley of death between lab and product.
- IdeaPublic co-investment in first-in-class phase 1 with a royalty return
Shares A diversified royalty pool that finances academic phase 1 trials across fifty assets, The valley of death between lab and product.
- IdeaMilestone-based venture philanthropy with royalties recycled into the pipeline
Shares A diversified royalty pool that finances academic phase 1 trials across fifty assets, The valley of death between lab and product.
- Key paperReproducibility Project: Cancer Biology found that landmark preclinical results mostly shrank or vanished on replication
Shares A national non-profit contract research organisation for academic oncology trials, The valley of death between lab and product.
- IdeaA pragmatic trial network for intraoperative margin tools, paid on margin reduction
Shares A translation fund for academic surgical devices and radiotherapy technology, The valley of death between lab and product.